Literature DB >> 16250394

Utility of magnetic resonance imaging for distinguishing neoplastic from non-neoplastic brain lesions in dogs and cats.

Giunio Bruto Cherubini1, Panagiotis Mantis, Teresa A Martinez, Christopher R Lamb, Rodolfo Cappello.   

Abstract

The aim of this study was to identify magnetic resonance (MR) signs that aid differentiation of neoplastic vs. non-neoplastic brain diseases in dogs and cats. MR images of 36 dogs and 13 cats with histologic diagnosis of intracranial disease were reviewed retrospectively. Diagnoses included 30 primary and three metastatic brain tumors, 11 infectious/inflammatory lesions, three vascular, one degenerative disease, and one developmental malformation. Upon univariate analysis of 21 MR signs, there were seven that had a significant association with neoplasia: single lesion (P = 0.004), shape (P = 0.015), mass effect (P = 0.002), dural contact (P = 0.04), dural tail (P = 0.005), lesions affecting adjacent bone (P = 0.008), and contrast enhancement (P = 0.025). Increasing age was also found to be associated with neoplasia (P = 0.0001). MR signs of non-neoplastic brain diseases in dogs and cats were more variable than those of brain neoplasia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250394     DOI: 10.1111/j.1740-8261.2005.00069.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  16 in total

1.  Correlating magnetic resonance findings with neuropathology and clinical signs in dogs and cats.

Authors:  Charles H Vite; Johnny R Cross
Journal:  Vet Radiol Ultrasound       Date:  2011 Mar-Apr       Impact factor: 1.363

2.  Intracranial nonthermal irreversible electroporation: in vivo analysis.

Authors:  Paulo A Garcia; John H Rossmeisl; Robert E Neal; Thomas L Ellis; John D Olson; Natalia Henao-Guerrero; John Robertson; Rafael V Davalos
Journal:  J Membr Biol       Date:  2010-07-29       Impact factor: 1.843

3.  Cholesterol granuloma in the choroid plexus of a cat.

Authors:  Rouven Wannemacher; Anna Knebel; Holger A Volk; Florian Hansmann
Journal:  BMC Vet Res       Date:  2022-06-27       Impact factor: 2.792

4.  Hyperintensity of Cerebrospinal Fluid on T2-Weighted Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging Caused by High Inspired Oxygen Fraction.

Authors:  Melania Moioli; Olivier Levionnois; Veronika M Stein; Gertraud Schüpbach; Marta Schmidhalter; Daniela Schweizer-Gorgas
Journal:  Front Vet Sci       Date:  2017-12-18

5.  Results of magnetic resonance imaging in 14 cats with meningoencephalitis.

Authors:  Arianna Negrin; Christopher R Lamb; Rodolfo Cappello; Giunio B Cherubini
Journal:  J Feline Med Surg       Date:  2006-10-17       Impact factor: 2.015

6.  Three-dimensional T1-weighted gradient echo is a suitable alternative to two-dimensional T1-weighted spin echo for imaging the canine brain.

Authors:  Kathryn L Fleming; Thomas W Maddox; Christopher M R Warren-Smith
Journal:  Vet Radiol Ultrasound       Date:  2019-05-30       Impact factor: 1.363

7.  MAGNETIC RESONANCE IMAGING FEATURES OF INTRAVENTRICULAR EPENDYMOMAS IN Five CATS.

Authors:  Antonia DeJesus; Eli B Cohen; Evelyn Galban; Jantra Ngosuwan Suran
Journal:  Vet Radiol Ultrasound       Date:  2016-12-20       Impact factor: 1.363

Review 8.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

9.  Exclusion of a brain lesion: is intravenous contrast administration required after normal precontrast magnetic resonance imaging?

Authors:  E J Ives; N Rousset; N Heliczer; M E Herrtage; A E Vanhaesebrouck
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

Review 10.  Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors.

Authors:  Andrew D Miller; C Ryan Miller; John H Rossmeisl
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.